These effects, together with a prior report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two assist the thought of concentrating on ACKR3 as a unique method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-r